Founded in 2008 by executives with extensive experience in medical manufacturing and healthcare investment banking, Portal Capital specializes in small-market private equity investments in life science companies. With a team that has over 50 years of combined experience in operations, finance, and marketing, the firm focuses on early-stage companies in North America, providing equity investments ranging from $250,000 to $2 million. They seek controlling or substantial-minority positions and employ various transaction structures such as leveraged buyouts, corporate divestitures, and growth financings. Portal Capital has a successful track record in sourcing, managing, and exiting equity investments, and has a particular interest in the healthcare and pharmaceutical sectors.